VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 394, doi. 10.1038/gt.2010.152
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2011 AND VI 18 AND IP 4
Results: 13
1
2
Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 344, doi. 10.1038/gt.2010.139
- By:
- Publication type:
- Article
3
Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 334, doi. 10.1038/gt.2010.149
- By:
- Publication type:
- Article
4
Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 411, doi. 10.1038/gt.2010.167
- By:
- Publication type:
- Article
5
Refined human artificial chromosome vectors for gene therapy and animal transgenesis.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 384, doi. 10.1038/gt.2010.147
- By:
- Publication type:
- Article
6
Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 403, doi. 10.1038/gt.2010.157
- By:
- Publication type:
- Article
7
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 326, doi. 10.1038/gt.2010.133
- By:
- Publication type:
- Article
8
A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 364, doi. 10.1038/gt.2010.144
- By:
- Publication type:
- Article
9
Ultrasound-assisted non-viral gene transfer to the salivary glands.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 424, doi. 10.1038/gt.2011.30
- By:
- Publication type:
- Article
10
Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention?
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 319, doi. 10.1038/gt.2010.164
- By:
- Publication type:
- Article
11
Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 418, doi. 10.1038/gt.2010.165
- By:
- Publication type:
- Article
12
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 354, doi. 10.1038/gt.2010.143
- By:
- Publication type:
- Article
13
RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
- Published in:
- Gene Therapy, 2011, v. 18, n. 4, p. 372, doi. 10.1038/gt.2010.146
- By:
- Publication type:
- Article